Role of HDAC2 in the Pathophysiology of COPD
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Chronic obstructive pulmonary disease (COPD), characterized by progressive inflammation in the small airways and lung parenchyma, is mediated by the increased expression of multiple inflammatory genes. The increased expression of these genes is regulated by acetylation of core histones, whereas histone deacetylase 2 (HDAC2) suppresses inflammatory gene expression. In COPD, HDAC2 activity and expression are reduced in peripheral lung and in alveolar macrophages, resulting in amplification of the inflammatory response. Corticosteroid resistance in COPD occurs because corticosteroids use HDAC2 to switch off activated inflammatory genes. The reduction in HDAC2 appears to be secondary to the increased oxidative and nitrative stress in COPD lungs. Antioxidants and inhibitors of nitric oxide synthesis may therefore restore corticosteroid sensitivity in COPD, but this can also be achieved by low concentrations of theophylline and curcumin, which act as HDAC activators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Self-citationThe Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Chronic Obstructive Pulmonary Disease
(2018) · Questions for the Final FFICM Structured Oral Examination · doi:10.1017/9781108233712.025 · Cited by 2,689
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,079
Functions of Site-Specific Histone Acetylation and Deacetylation
Shahbazian, M. D., & Grunstein, M. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052705.162114 · Cited by 1,635
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
Self-citationImmunology of asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2254 · Cited by 1,399
Self-citationPathophysiology of airflow limitation in chronic obstructive pulmonary disease
Hogg, J. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16900-6 · Cited by 1,294
Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update
Fabbri, L. M., & Hurd, S. S. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00063703 · Cited by 1,277
Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430407 · Cited by 1,078
Self-citationThe cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Self-citationDecreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease
Ito, K., Ito, M., Elliott, W. M., Cosio, B., Caramori, G., Kon, O. M., Barczyk, A., Hayashi, S., Adcock, I. M., Hogg, J. C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041892 · Cited by 968
Self-citationHow corticosteroids control inflammation: Quintiles Prize Lecture 2005
Barnes, P. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706736 · Cited by 838
Self-citationDeveloping COPD: a 25 year follow up study of the general population
Lokke, A., Lange, P., Scharling, H., Fabricius, P., & Vestbo, J. (2006) · Thorax · doi:10.1136/thx.2006.062802 · Cited by 730
Ito, K., Barnes, P. J., & Adcock, I. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6891-6903.2000 · Cited by 723
Self-citationMediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Self-citationHistone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638 · cited 4×
“with a plasmid vector of HDAC2 reverses corticosteroid resistance in these cells, whereas transfection with an HDAC1 vector is without effect (37).”
BackgroundInfluentialSelf-citationHistone acetylation and deacetylation: importance in inflammatory lung diseases
Barnes, P. J., Adcock, I. M., & Ito, K. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00117504 · Cited by 564
Self-citationEffects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Keatings, V. M., Jatakanon, A., Worsdell, Y. M., & Barnes, P. J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.2.9032192 · Cited by 558
Self-citationThomson, N. C., Chaudhuri, R., & Livingston, E. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00039004 · Cited by 555
MONTUSCHI, P., COLLINS, J. V., CIABATTONI, G., LAZZERI, N., CORRADI, M., KHARITONOV, S. A., & BARNES, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.2001063 · Cited by 548
Self-citationInhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Clarke, M. S., Sim, E. H., & Fong, K. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991.pub3 · Cited by 523
Ito, K., Lim, S., Caramori, G., Cosio, B., Chung, K. F., Adcock, I. M., & Barnes, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132556899 · Cited by 512
Self-citationRahman, I., Marwick, J., & Kirkham, P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.042 · Cited by 507 · cited 1×
“However, there is increasing evidence that the reduction may be due Oxidative stress: an excessive number of reactive oxygen species compared with the number of antioxidant molecules to inactivation of the enzyme by oxidative and nitrative stress (42, 50) (Figure 6).”
BackgroundITO, K., LIM, S., CARAMORI, G., CHUNG, K. F., BARNES, P. J., & ADCOCK, I. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0432fje · Cited by 481
Self-citationTheophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
Cosio, B. G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I. M., & Barnes, P. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040416 · Cited by 473
Self-citationOxidative stress in asthma and COPD: Antioxidants as a therapeutic strategy
Kirkham, P., & Rahman, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.015 · Cited by 470
Exacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Self-citationRussell, R. E. K., Culpitt, S. V., DeMatos, C., Donnelly, L., Smith, M., Wiggins, J., & Barnes, P. J. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.5.4685 · Cited by 448
Self-citationIncreased expression of nuclear factor-κB in bronchial biopsies from smokers and patients with COPD
Di Stefano, A., Caramori, G., Oates, T., Capelli, A., Lusuardi, M., Gnemmi, I., Ioli, F., Chung, K. F., Donner, C. F., Barnes, P. J., et al. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00272002 · Cited by 429
Self-citationCULPITT, S. V., MAZIAK, W., LOUKIDIS, S., NIGHTINGALE, J. A., MATTHEWS, J. L., & BARNES, P. J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.5.9811058 · Cited by 417
Self-citationBarnes, P. J., Ito, K., & Adcock, I. M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15650-x · Cited by 399
Self-citationHow Do Corticosteroids Work in Asthma?
Barnes, P. J., & Adcock, I. M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-5_part_1-200309020-00012 · Cited by 371
Self-citationIto, K., Hanazawa, T., Tomita, K., Barnes, P. J., & Adcock, I. M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.046 · Cited by 370
Self-citationAlveolar Macrophages as Orchestrators of COPD
Barnes, P. J. (2004) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-120028701 · Cited by 360
Self-citationCulpitt, S. V., Rogers, D. F., Shah, P., De Matos, C., Russell, R. E. K., Donnelly, L. E., & Barnes, P. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-298oc · Cited by 333
Self-citationEffect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Willemse, B. W. M., ten Hacken, N. H. T., Rutgers, B., Lesman-Leegte, I. G. A. T., Postma, D. S., & Timens, W. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00108904 · Cited by 322
Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2006) · Chest · doi:10.1378/chest.129.2.317 · Cited by 317
Expression and Activity of Histone Deacetylases in Human Asthmatic Airways
Ito, K., Caramori, G., Lim, S., Oates, T., Chung, K. F., Barnes, P. J., & Adcock, I. M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110060 · Cited by 306
Self-citationCigarette Smoke Alters Chromatin Remodeling and Induces Proinflammatory Genes in Rat Lungs
Marwick, J. A., Kirkham, P. A., Stevenson, C. S., Danahay, H., Giddings, J., Butler, K., Donaldson, K., MacNee, W., & Rahman, I. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0006oc · Cited by 301
Exhaled Ethane, a Marker of Lipid Peroxidation, Is Elevated in Chronic Obstructive Pulmonary Disease
PAREDI, P., KHARITONOV, S. A., LEAK, D., WARD, S., CRAMER, D., & BARNES, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9909025 · Cited by 297
Self-citationRelative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe Asthma
Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P. J., Adcock, I., & Fan Chung, K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1930oc · Cited by 271
Self-citation8-Isoprostane as a Biomarker of Oxidative Stress in Interstitial Lung Diseases
MONTUSCHI, P., TONI, G. C., PAREDI, P., PANTELIDIS, P., du BOIS, R. M., KHARITONOV, S. A., & BARNES, P. J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.5.9803102 · Cited by 267
Self-citationCOPD: current therapeutic interventions and future approaches
Barnes, P. J., & Stockley, R. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00139104 · Cited by 259
Self-citationBhavsar, P., Hew, M., Khorasani, N., Torrego, A., Barnes, P. J., Adcock, I., & Chung, K. F. (2008) · Thorax · doi:10.1136/thx.2007.090027 · Cited by 246
Self-citationDyspnea and Activity Limitation in COPD: Mechanical Factors
O'Donnell, D. E., & Laveneziana, P. (2007) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701480455 · Cited by 220 · cited 1×
“This leads to the characteristic hyperinflation of the lungs, which gives rise to the sensation of dyspnea and limits exercise capacity (14).”
BackgroundCaramori, G. (2003) · Thorax · doi:10.1136/thorax.58.4.348 · Cited by 216
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis
Montuschi, P. (2000) · Thorax · doi:10.1136/thorax.55.3.205 · Cited by 214
Hansel, T. T., Kharitonov, S. A., Donnelly, L. E., Erin, E. M., Currie, M. G., Moore, W. M., Manning, P. T., Recker, D. P., & Barnes, P. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0633fje · Cited by 208 · cited 1×
“formation (62) but may not prevent the generation of peroxynitrite from nitric oxide in cigarette smoke.”
BackgroundSelf-citationExhaled nitric oxide from lung periphery is increased in COPD
Brindicci, C., Ito, K., Resta, O., Pride, N. B., Barnes, P. J., & Kharitonov, S. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00125304 · Cited by 206 · cited 1×
“Nitrative stress is also increased in the peripheral lungs of COPD patients (54), and there is increased expression of inducible nitric oxide synthase (iNOS) in small airways and the lung parenchyma (55).”
BackgroundCurcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2
Meja, K. K., Rajendrasozhan, S., Adenuga, D., Biswas, S. K., Sundar, I. K., Spooner, G., Marwick, J. A., Chakravarty, P., Fletcher, D., Whittaker, P., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0012oc · Cited by 206
The Immunopathogenesis of Chronic Obstructive Pulmonary Disease: Insights from Recent Research
Curtis, J. L., Freeman, C. M., & Hogg, J. C. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200701-002fm · Cited by 192
Prospects for new drugs for chronic obstructive pulmonary disease
Barnes, P. J., & Hansel, T. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17025-6 · Cited by 189
Self-citationChen, Y., Shu, W., Chen, W., Wu, Q., Liu, H., & Cui, G. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00142.x · Cited by 187
Szulakowski, P., Crowther, A. J. L., Jiménez, L. A., Donaldson, K., Mayer, R., Leonard, T. B., MacNee, W., & Drost, E. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-725oc · Cited by 176
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Gamble, E., Grootendorst, D. C., Hattotuwa, K., O'Shaughnessy, T., Ram, F. S. F., Qiu, Y., Zhu, J., Vignola, A. M., Kroegel, C., Morell, F., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00013006 · Cited by 168
The Role of Oxidative Stress in Chronic Obstructive Pulmonary Disease
Bowler, R. P., Barnes, P. J., & Crapo, J. D. (2004) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200027031 · Cited by 166
Self-citationChronic Obstructive Pulmonary Disease: A Growing but Neglected Global Epidemic
Barnes, P. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040112 · Cited by 165
Self-citationReduced Histone Deacetylase in COPD
Barnes, P. J. (2006) · Chest · doi:10.1378/chest.129.1.151 · Cited by 161
Self-citationInhaled corticosteroids for stable chronic obstructive pulmonary disease
Yang, I. A., Fong, K., Sim, E. H. A., Black, P. N., & Lasserson, T. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002991.pub2 · Cited by 153
Epigenetics and airways disease
Adcock, I. M., Ford, P., Ito, K., & Barnes, P. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-21 · Cited by 152
Self-citationNitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease
Ricciardolo, F. L. M., Caramori, G., Ito, K., Capelli, A., Brun, P., Abatangelo, G., Papi, A. A., Chung, K. F., Adcock, I. M., Barnes, P. J., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.06.034 · Cited by 151
Self-citationChemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
Donnelly, L., & Barnes, P. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.08.001 · Cited by 137
Self-citationTranscription factors in airway diseases
Barnes, P. J. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700456 · Cited by 132
Self-citationParedi, P., Kharitonov, S. A., LEAK, D., Shah, P. L., Cramer, D., Hodson, M. E., & Barnes, P. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9906122 · Cited by 110
Self-citationDecramer, M., Mölken, M. R., Dekhuijzen, P. N. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, O. C. P., Olivieri, D., Donno, M. D., Backer, W. D., et al. (2005) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2005.09.021 · Cited by 103
The functional significance of nuclear receptor acetylation
Popov, V. M., Wang, C., Shirley, L. A., Rosenberg, A., Lisanti, M. P., Nevalainen, M. T., Fu, M., & Pestell, R. G. (2007) · Steroids · doi:10.1016/j.steroids.2006.12.001 · Cited by 90
Progress in Chronic Obstructive Pulmonary Disease Genetics
Silverman, E. K. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-092aw · Cited by 83
Marwick, J. A., Ito, K., Adcock, I. M., & Kirkham, P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.745 · Cited by 82
Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment
Barnes, P. J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.6.1111 · Cited by 51
Self-citationFrontrunners in novel pharmacotherapy of COPD
Barnes, P. J. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.03.001 · Cited by 46
Self-citationOvercoming steroid insensitivity in smoking asthmatics.
Ahmad, T., Barnes, P. J., & Adcock, I. M. (2008) · PubMed · Cited by 24
Self-citation
Cited by
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Barnes, P. J. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.05.011 · Cited by 1,683
Self-citationGlucocorticosteroids: current and future directions
Barnes, P. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01199.x · Cited by 533
Self-citationDelcuve, G. P., Khan, D. H., & Davie, J. R. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-5 · Cited by 505
Cellular and molecular mechanisms of asthma and COPD
Barnes, P. J. (2017) · Clinical Science · doi:10.1042/cs20160487 · Cited by 511
Self-citation
Metadata
- Authors
- Barnes, P. J.
- Venue
- Annual Review of Physiology
- Publisher
- Annual Reviews
- Published
- 2009-03-01
- Volume
- 71
- Issue
- 1
- Pages
- 451-464
- ISSN
- 0066-4278 (ISSN-L)
- 1545-1585
- OpenAlex
- W2125525438
- Cited by
- 318
- References
- 76
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.